Mark Roger

Zoledronate for prevention of bone erosion in tophaceous gout: a randomised, double-blind, placebo-controlled trial

Nicola Dalbeth, Opetaia Aati, Gregory D. Gamble et al. · Annals of the Rheumatic Diseases · 2014 · 26 citations

Path Analysis Identifies Receptor Activator of Nuclear Factor-κB Ligand, Osteoprotegerin, and Sclerostin as Potential Mediators of the Tophus-bone Erosion Relationship in Gout

Ashika Chhana, Opetaia Aati, Gregory D. Gamble et al. · The Journal of Rheumatology · 2016 · 14 citations

<scp>CT</scp> enterography: Mannitol versus VoLumen

Jessica Wong, Helen Moore, Mark Roger et al. · Journal of Medical Imaging and Radiation Oncology · 2016 · 12 citations

Performance of two neutral oral contrast agents in <scp>CT</scp> enterography

Jessica Wong, Mark Roger, Helen Moore · Journal of Medical Imaging and Radiation Oncology · 2014 · 11 citations